RATTI, ANTONIA
RATTI, ANTONIA
Dipartimento di Biotecnologie Mediche e Medicina Traslazionale
Unleashing the potential of mRNA therapeutics for inherited neurological diseases
2024 E. Monfrini, G. Baso, D. Ronchi, M. Meneri, D. Gagliardi, L. Quetti, F. Verde, N. Ticozzi, A. Ratti, A. Di Fonzo, G.P. Comi, L. Ottoboni, S. Corti
Shaping the Neurovascular Unit Exploiting Human Brain Organoids
2024 M. Rizzuti, V. Melzi, L. Brambilla, L. Quetti, L. Sali, L. Ottoboni, M. Meneri, A. Ratti, F. Verde, N. Ticozzi, G.P. Comi, S. Corti, E. Abati
Relationship between cerebrospinal fluid/serum albumin quotient and phenotype in amyotrophic lateral sclerosis: a retrospective study on 328 patients
2023 F. Verde, I. Ferrari, A. Maranzano, E. Ciusani, S. Torre, I. Milone, E. Colombo, A. Doretti, S. Peverelli, A. Ratti, L. Maderna, B. Poletti, S. Messina, C. Morelli, V. Silani, N. Ticozzi
Phenotypic correlates of serum neurofilament light chain levels in amyotrophic lateral sclerosis
2023 F. Verde, I. Milone, E. Colombo, A. Maranzano, F. Solca, S. Torre, A. Doretti, F. Gentile, A. Manini, R. Bonetti, S. Peverelli, S. Messina, L. Maderna, C. Morelli, B. Poletti, A. Ratti, V. Silani, N. Ticozzi
Rapamycin reverts TDP-43 splicing defects and mislocalization in human in vitro models of TDP-43 proteinopathy
2023 V. Casiraghi, C. Colombrita, S. Santangelo, S. Invernizzi, M.N. Sorce, P. Bossolasco, V. Silani, A. Ratti
Identification of Novel Biomarkers of Spinal Muscular Atrophy and Therapeutic Response by Proteomic and Metabolomic Profiling of Human Biological Fluid Samples
2023 M. Meneri, E. Abati, D. Gagliardi, I. Faravelli, V. Parente, A. Ratti, F. Verde, N. Ticozzi, G.P. Comi, L. Ottoboni, S. Corti
Coexistence of Amyotrophic Lateral Sclerosis and Alzheimer’s Disease: Case Report and Review of the Literature
2023 F. Verde, E.N. Aiello, L. Adobbati, B. Poletti, F. Solca, C. Tiloca, D. Sangalli, A. Maranzano, C. Muscio, A. Ratti, S. Zago, N. Ticozzi, G.B. Frisoni, V. Silani
Exploring epigenetic drift and rare epivariations in amyotrophic lateral sclerosis by epigenome-wide association study
2023 A. Brusati, S. Peverelli, L. Calzari, C. Tiloca, V. Casiraghi, M.N. Sorce, S. Invernizzi, E. Carbone, R. Cavagnola, F. Verde, V. Silani, N. Ticozzi, A. Ratti, D. Gentilini
Influence of kidney function and CSF/serum albumin ratio on plasma Aβ42 and Aβ40 levels measured on a fully automated platform in patients with Alzheimer’s disease
2023 F. Verde, I. Milone, A. Dubini, C. Colombrita, A. Perego, F. Solca, A. Maranzano, E. Ciusani, B. Poletti, A. Ratti, E. Torresani, V. Silani, N. Ticozzi
Lower semantic fluency scores and a phonemic-over-semantic advantage predict abnormal CSF P-tau181 levels in Aβ + patients within the Alzheimer's disease clinical spectrum
2023 E.N. Aiello, F. Verde, F. Solca, I. Milone, E. Giacopuzzi Grigoli, A. Dubini, A. Ratti, R. Ferrucci, E. Torresani, A. Priori, N. Ticozzi, V. Silani, B. Poletti
Generation of five induced pluripotent stem cells lines from four members of the same family carrying a C9orf72 repeat expansion and one wild-type member
2023 C. Lattuada, S. Santangelo, S. Peverelli, P. Mcgoldrick, E. Rogaeva, L. Zinman, G. Haase, V. Géli, V. Silani, J. Robertson, A. Ratti, P. Bossolasco
U1 snRNA as a novel RNA-based therapeutic approach to modulate C9ORF72 pathology in patient-derived iPSC-motoneurons
2023 S. Invernizzi, S. Santangelo, E. Bussani, G. Romano, C. Colombrita, V. Casiraghi, M. Nice Sorce, P. Bossolasco, V. Silani, F. Pagani, A. Ratti
Molecular mechanisms in KIF5A-related neurodegeneration
2023 M. Cozzi, B. Tedesco, V. Ferrari, E. Casarotto, M. Chierichetti, P. Pramaggiore, M. Piccolella, M. Galbiati, P. Rusmini, V. Crippa, C. Gellera, S. Magri, S. Santangelo, A. Ratti, R. Cristofani, F. Taroni, A. Poletti
Generation of an iPSC line from a patient with spastic paraplegia type 10 carrying a novel mutation in KIF5A gene
2023 S. Santangelo, P. Bossolasco, S. Magri, C. Colombrita, S. Invernizzi, C. Gellera, L. Nanetti, D. Di Bella, V. Silani, F. Taroni, A. Ratti
Phosphorylated tau in plasma could be a biomarker of lower motor neuron impairment in amyotrophic lateral sclerosis
2023 F. Verde, I. Milone, E. Colombo, A. Maranzano, A. Dubini, C. Colombrita, F. Gentile, A. Doretti, S. Torre, S. Messina, C. Morelli, E. Torresani, B. Poletti, A. Priori, L. Maderna, A. Ratti, V. Silani, N. Ticozzi
Clinical and molecular features of patients with amyotrophic lateral sclerosis and SOD1 mutations: a monocentric study
2023 D. Gagliardi, P. Ripellino, M. Meneri, R. Del Bo, S. Antognozzi, G.P. Comi, C. Gobbi, A. Ratti, N. Ticozzi, V. Silani, D. Ronchi, S. Corti
Serum levels of glial fibrillary acidic protein in patients with amyotrophic lateral sclerosis
2023 F. Verde, I. Milone, A. Maranzano, E. Colombo, S. Torre, F. Solca, A. Doretti, F. Gentile, A. Manini, R. Bonetti, S. Peverelli, S. Messina, L. Maderna, C. Morelli, B. Poletti, A. Ratti, V. Silani, N. Ticozzi
Genetic variability in sporadic amyotrophic lateral sclerosis
2023 S.H. Van Daele, M. Moisse, J.J.F.A. van Vugt, R.A.J. Zwamborn, R. van der Spek, W. van Rheenen, K. Van Eijk, K. Kenna, P. Corcia, P. Vourc'H, P. Couratier, O. Hardiman, R. Mclaughin, M. Gotkine, V. Drory, N. Ticozzi, V. Silani, A. Ratti, M. de Carvalho, J.S. Mora Pardina, M. Povedano, P.M. Andersen, M. Weber, N.A. Başak, C. Shaw, P.J. Shaw, K.E. Morrison, J.E. Landers, J.D. Glass, M.A. van Es, L.H. van den Berg, A. Al-Chalabi, J. Veldink, P. Van Damme
Human motor neurons derived from induced pluripotent stem cells are susceptible to SARS-CoV-2 infection
2023 G. Cappelletti, C. Colombrita, F. Limanaqi, S. Invernizzi, M. Garziano, C. Vanetti, C. Moscheni, S. Santangelo, S. Zecchini, D. Trabattoni, V. Silani, M. Clerici, A. Ratti, M. Biasin
Association of the risk factor UNC13A with survival and upper motor neuron involvement in amyotrophic lateral sclerosis
2023 A. Manini, V. Casiraghi, A. Brusati, A. Maranzano, F. Gentile, E. Colombo, R. Bonetti, S. Peverelli, S. Invernizzi, D. Gentilini, S. Messina, F. Verde, B. Poletti, I. Fogh, C. Morelli, V. Silani, A. Ratti, N. Ticozzi